Management Of Venous Thromboembolism: Optimization By Clinical Trials

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue , 1996, Pages 220-226

  Turpie, Alexander G G ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulant therapy; Deep vein thrombosis; Heparin; Low molecular weight heparin; Randomized trials; Warfarin

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM;

ANTICOAGULANTS; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS; THROMBOLYTIC THERAPY; THROMBOPHLEBITIS; WARFARIN;

EID: 0029902226     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217302     Document Type: Article

References (20)

1. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Progress in Cardiovascular Disease 1975; 17:257-270.
2. Brandjes DPM, Heijboer H, Biiller HR, de Rijk M, Jagt H, ten Cate JW. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal vein thrombosis. N Engl J Med 1992; 327:1485-1489.
3. Salzman EW, Deykin D, Mayer Shapiro R, Rosenberg R. Management of heparin therapy: controlled prospective trial. N Engl J Med 1975; 292: 1046-1050.
4. Hommes DW, Bura A, Mazzolai L, Biiller HR, tenCate JW. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis.Metaanalysis Annals of Internal Medicine 1992; 116:279-284
5. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 1995; 108 (4):335S-352S.
6. Gallus A, Jackaman J, Tillet J, Mills W, Wycherley A. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 1986; 11:1293-1296.
7. Hull RD, Raskob GE, Rosenbloom D, Panju AA, Brill-Edwards P, Ginsberg JS, Hirsh J, Martin GJ, Green D. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis N Engl J Med 1990; 322:1260-1264.
8. Hull RD, Deimore T, Genton E, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979; 301:855-859.
9. Research Commitee of the British Thoracic Society. Optimal duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet 1992; 340:873-876.
10. Prandoni P, Lensing AWA, Buller HR et al. Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1993; 327,1128-1133.
11. Schulman S et al. Duration of anticoagulant therapy for venous thromboembolism. N Engl J Med 1995;332:16-61.
12. Hull RD, Deimore T, Carter C et al. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 1982; 306:189-194.
13. Hull RD, Hirsh J, Jay R, et al. Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis. N Engl J Med 1982; 307:1676-1681.
14. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79 (1): 1-17.
15. Lensing AWA, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch of Intern Med 1995; 155:601-607.
16. Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. Brit Med Journal 1994;309:648-651.
17. Siragusa S, Cosmi B, Piovella F, Hirsh J, Ginsberg G. Low molecular weight heparins and unfractionatd heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis. Am J of Medicine 1996; 100: 269-277.
18. Levine M, Gent M, Hirsh J et al. A comparison of low-molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis N Engl J Med 1996; 334 (11):677-681.
19. Koopman MMW, Prandoni P, Piovella F et al. (for the TASMAN Study Group). Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home N Engl J Med 1996; 334 (11):682-687.
20. Turpie AGG. Thrombolytic therapy in venous thrombosis and pulmonary embolism. Fibrinolysis 1994; 8 (1):237-244.